Ariel Fund Re Adds BMY Shaping India Investments
The latest move by Ariel Global Fund to re-add Bristol-Myers Squibb Company (BMY) to its portfolio is sending shockwaves across the global investments scene. This strategic shift, driven by the fund’s assessment of the company’s pipeline strength and attractive valuation, is not only significant for BMY shareholders but also has far-reaching implications for India’s investments […]
Ariel Fund Re Adds BMY Shaping India Investments Read More »










